Evdokia Anagnostou, MD, BSc

Dr. Evdokia Anagnostou is a child neurologist, professor of pediatrics at the University of Toronto, senior clinician scientist and director of the Bloorview Research Institute, and vice president of research at Holland Bloorview Kids Rehabilitation Hospital.

She leads multiple research and clinical trial networks, including the Province of Ontario Neurodevelopmental Disorders Network, a team studying brain development through multiple health measures. She also directs KINDtrials, a national clinical trial network dedicated to child development and pediatric disability, and the Canadian Precision Health Initiative for Neurodevelopment, a major personalized health program. Additionally, Anagnostou co-leads national research groups, including RareKids-Can and the Maternal Infant Child and Youth Research Network.

Throughout her career, she has managed extensive clinical trials sponsored by academic institutions and pharmaceutical companies. She has secured more than $75 million in research funding as principal investigator, as well as more than $100 million as a co-applicant and collaborator from global funding agencies. Anagnostou has authored or co-authored more than 280 peer-reviewed research papers. She previously held a Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder, and currently holds the Dr. Stuart D. Sims Chair in Autism.